Skip to main content

Table 2 Health status of participants with pain and without pain

From: Pain in amaXhosa women living with HIV/AIDS: a cross-sectional study of ambulant outpatients

 

Pain group

Pain Free Group

 
 

Mean ± SD

Mean ± SD

Significance Test

Most recent CD4+ count

n = 16

n = 56

 

 cells/microL

5328.36 ± 206.97

338.68 ± 227.55

t = 0.31; p = 0.75

Time since diagnosis

n = 10

n = 40

 

 Years

4.3 ± 3.3

3.8 ± 3.2

t = 1.01; p = 0.31

Time since initiating treatment

n = 169

n = 57

 

 Months

24.5 ± 22.3

21.9 ± 18.1

t = 0.57; p = 0.57

 

Number (%)

Number (%)

 

Current Clinical Stage (I – IV)

n = 162

n = 55

χ 2 = 1.41; p = 0.23

 HIV+ (Stage I and II)

59 (36)

25 (45)

 

 AIDS (Stage III and IV)

103 (64)

30 (55)

 

Current HIV/AIDS Management

n = 169

n = 57

χ 2 = 12.12; p = 0.02

 Monitoring

17 (10.00)

3 (5.08)

 

 First Line ARVs

137 (80.59)

44 (74.58)

 

 Second Line ARVs

12 (7.06)

3 (5.08)

 

 Pregnancy Prophylaxis

2 (1.18)

4 (6.78)

 

 Defaulted

1 (0.59)

3 (5.08)

 

Opportunistic Infections

   

 Tuberculosis

19 (11)

2 (3)

χ 2 = 3.18; p = 0.07

 Candidiasis

7 (4)

2 (3)

χ 2 = 0.06; p = 0.8

 Other infections (genital herpes, papular pruritic eruptions, meningitis, pneumocystis pneumonia, arthralgia)

10 (6)

0 (0)

χ 2 = 3.63; p = 0.06